Skip to main content

Advertisement

SpringerLink
Log in

Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancer

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Tetraspanin CD151 is known to be involved in cancer invasion and metastasis, and its overexpression appears to be associated with a poor prognosis for various types of cancer. However, the expression status of CD151 and its prognostic impact in advanced gastric cancer (AGC) has not yet been clarified.

Methods

Immunohistochemistry was used to investigate the expression of CD151, c-erbB2, and c-Met in 159 cases of AGC. The clinicopathological and prognostic significance of these biomarkers were then evaluated.

Results

The overexpression of CD151 was observed in a subset of advanced gastric adenocarcinomas (25.8 %), and c-erbB2 and c-Met were overexpressed in 15.1 and 35.2 % of the cohort, respectively. CD151 overexpression was more frequently observed in tumors from younger patients (P = 0.028). There were close associations between CD151 and c-erbB2 overexpression (P = 0.033) and between c-erbB2 and c-Met overexpression (P = 0.001). CD151 overexpression was closely correlated with patient’ overall survival (OS; P < 0.001) and disease-free survival (DFS; P < 0.001). Furthermore, the expression rate of CD151 seemed to increase gradually according to the depth of invasion (T stage) (χ 2 test for trend; P = 0.101), N stage (P = 0.238), and pathologic stage (P = 0.153), although trends were not statistically significant. In a multivariate analysis, CD151 overexpression was an independent prognostic factor predicting worse OS (P = 0.002) and DFS (P = 0.005), along with the T and N stage.

Conclusions

CD151 was found to be an independent prognostic marker for patients with AGC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Ruschoff J, Kang YK (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697

    Article  PubMed  CAS  Google Scholar 

  • Blum MA, Takashi T, Suzuki A, Ajani JA (2013) Management of localized gastric cancer. J Surg Oncol 107:265–270

    Article  PubMed  Google Scholar 

  • Deng X, Li Q, Hoff J, Novak M, Yang H, Jin H, Erfani SF, Sharma C, Zhou P, Rabinovitz I, Sonnenberg A, Yi Y, Zhou P, Stipp CS, Kaetzel DM, Hemler ME, Yang XH (2012) Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis. Neoplasia 14:678–689

    PubMed  CAS  Google Scholar 

  • Franco M, Muratori C, Corso S, Tenaglia E, Bertotti A, Capparuccia L, Trusolino L, Comoglio PM, Tamagnone L (2010) The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth. J Biol Chem 285:38756–38764

    Article  PubMed  CAS  Google Scholar 

  • Guggenheim DE, Shah MA (2013) Gastric cancer epidemiology and risk factors. J Surg Oncol 107:230–236

    Article  PubMed  Google Scholar 

  • Ha SY, Lee J, Kang SY, Do IG, Ahn S, Park JO, Kang WK, Choi MG, Sohn TS, Bae JM, Kim S, Kim M, Kim S, Park CK, Ignatius Ou SH, Kim KM (2013) MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas. Mod Pathol [Epub ahead of print]

  • Hemler ME (2008) Targeting of tetraspanin proteins–potential benefits and strategies. Nat Rev Drug Discov 7:747–758

    Article  PubMed  CAS  Google Scholar 

  • Huang XY, Ke AW, Shi GM, Ding ZB, Devbhandari RP, Gu FM, Li QL, Dai Z, Zhou J, Fan J (2010) Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients. Cancer 116:5440–5451

    Article  PubMed  CAS  Google Scholar 

  • Jain S, Filipe MI, Gullick WJ, Linehan J, Morris RW (1991) c-erbB-2 proto-oncogene expression and its relationship to survival in gastric carcinoma: an immunohistochemical study on archival material. Int J Cancer 48:668–671

    Article  PubMed  CAS  Google Scholar 

  • Jorgensen JT, Hersom M (2012) HER2 as a prognostic marker in gastric cancer—a systematic analysis of data from the literature. J Cancer 3:137–144

    Article  PubMed  Google Scholar 

  • Kang BW, Kim JG, Chae YS, Lee YJ, Lee SJ, Moon JH, Sohn SK, Jung MK, Jeon SW, Jang YJ, Seo J, Lee YH, Kwon O, Chung HY, Yu W (2012) Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer. Invest New Drugs 30:1671–1675

    Article  PubMed  CAS  Google Scholar 

  • Ke AW, Shi GM, Zhou J, Wu FZ, Ding ZB, Hu MY, Xu Y, Song ZJ, Wang ZJ, Wu JC, Bai DS, Li JC, Liu KD, Fan J (2009) Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology 49:491–503

    Article  PubMed  CAS  Google Scholar 

  • Kim KC, Koh YW, Chang HM, Kim TH, Yook JH, Kim BS, Jang SJ, Park YS (2011) Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays. Ann Surg Oncol 18:2833–2840

    Article  PubMed  Google Scholar 

  • Klosek SK, Nakashiro K, Hara S, Shintani S, Hasegawa H, Hamakawa H (2005) CD151 forms a functional complex with c-Met in human salivary gland cancer cells. Biochem Biophys Res Commun 336:408–416

    Article  PubMed  CAS  Google Scholar 

  • Kunz PL, Mojtahed A, Fisher GA, Ford JM, Chang DT, Balise RR, Bangs CD, Cherry AM, Pai RK (2012) HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment. Appl Immunohistochem Mol Morphol 20:13–24

    Article  PubMed  CAS  Google Scholar 

  • Kwon MJ, Park S, Choi JY, Oh E, Kim YJ, Park YH, Cho EY, Kwon MJ, Nam SJ, Im YH, Shin YK, Choi YL (2012) Clinical significance of CD151 overexpression in subtypes of invasive breast cancer. Br J Cancer 106:923–930

    Article  PubMed  CAS  Google Scholar 

  • Lee KE, Lee HJ, Kim YH, Yu HJ, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP (2003) Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. Jpn J Clin Oncol 33:173–179

    Article  PubMed  Google Scholar 

  • Lee J, Seo JW, Jun HJ, Ki CS, Park SH, Park YS, Lim HY, Choi MG, Bae JM, Sohn TS, Noh JH, Kim S, Jang HL, Kim JY, Kim KM, Kang WK, Park JO (2011) Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target. Oncol Rep 25:1517–1524

    PubMed  CAS  Google Scholar 

  • Lee D, Suh YL, Park TI, Do IG, Seol HJ, Nam DH, Kim ST (2012a) Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas. J Surg Oncol 107(6):646–652

    Article  PubMed  Google Scholar 

  • Lee HE, Kim MA, Lee HS, Jung EJ, Yang HK, Lee BL, Bang YJ, Kim WH (2012b) MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome. Br J Cancer 107:325–333

    Article  PubMed  CAS  Google Scholar 

  • Romanska HM, Berditchevski F (2011) Tetraspanins in human epithelial malignancies. J Pathol 223:4–14

    Article  PubMed  CAS  Google Scholar 

  • Ross JS, Slodkowska EA, Symmans WF, Pusztai L, Ravdin PM, Hortobagyi GN (2009) The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine. Oncol 14:320–368

    Article  CAS  Google Scholar 

  • Sadej R, Romanska H, Kavanagh D, Baldwin G, Takahashi T, Kalia N, Berditchevski F (2010) Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in tumor metastasis. Cancer Res 70:6059–6070

    Article  PubMed  CAS  Google Scholar 

  • Suzuki S, Miyazaki T, Tanaka N, Sakai M, Sano A, Inose T, Sohda M, Nakajima M, Kato H, Kuwano H (2011) Prognostic significance of CD151 expression in esophageal squamous cell carcinoma with aggressive cell proliferation and invasiveness. Ann Surg Oncol 18:888–893

    Article  PubMed  Google Scholar 

  • Testa JE, Brooks PC, Lin JM, Quigley JP (1999) Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res 59:3812–3820

    PubMed  CAS  Google Scholar 

  • Viudez-Berral A, Miranda-Murua C, Arias-de-la-Vega F, Hernandez-Garcia I, Artajona-Rosino A, Diaz-de-Liano A, Vera-Garcia R (2012) Current management of gastric cancer. Rev Esp Enferm Dig 104:134–141

    Article  PubMed  Google Scholar 

  • Voss MA, Gordon N, Maloney S, Ganesan R, Ludeman L, McCarthy K, Gornall R, Schaller G, Wei W, Berditchevski F, Sundar S (2011) Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer. Br J Cancer 104:1611–1618

    Article  PubMed  CAS  Google Scholar 

  • Yan SY, Hu Y, Fan JG, Tao GQ, Lu YM, Cai X, Yu BH, Du YQ (2011) Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma. World J Gastroenterol 17:1501–1506

    Article  PubMed  CAS  Google Scholar 

  • Yang XH, Richardson AL, Torres-Arzayus MI, Zhou P, Sharma C, Kazarov AR, Andzelm MM, Strominger JL, Brown M, Hemler ME (2008) CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res 68:3204–3213

    Article  PubMed  CAS  Google Scholar 

  • Yang XH, Flores LM, Li Q, Zhou P, Xu F, Krop IE, Hemler ME (2010) Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists. Cancer Res 70:2256–2263

    Article  PubMed  CAS  Google Scholar 

  • Yang YM, Zhang ZW, Liu QM, Sun YF, Yu JR, Xu WX (2013) Overexpression of CD151 predicts prognosis in patients with resected gastric cancer. PLoS ONE 8:e58990

    Article  PubMed  CAS  Google Scholar 

  • Yoo SH, Lee K, Chae JY, Moon KC (2011) CD151 expression can predict cancer progression in clear cell renal cell carcinoma. Histopathology 58:191–197

    Article  PubMed  Google Scholar 

  • Zoller M (2009) Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 9:40–55

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by Kyungpook National University Research Fund, 2011.

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Hematology/Oncology, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Republic of Korea

    Byung Woog Kang

  2. Department of Pathology, Kyungpook National University Hospital, Kyungpook National University School of Medicine, 2-101 Dongin-dong, Jung-gu, Daegu, 135-710, Republic of Korea

    Dakeun Lee

  3. Department of Surgery, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Republic of Korea

    Ho Young Chung

  4. Department of Pathology, Ajou University School of Medicine, 164, Worldcup-ro, Yeongtong-gu, Suwon, 443-380, Republic of Korea

    Jae Ho Han & Young-Bae Kim

Authors
  1. Byung Woog Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dakeun Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ho Young Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jae Ho Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Young-Bae Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Dakeun Lee or Young-Bae Kim.

Additional information

Dakeun Lee and Young-Bae Kim have contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kang, B.W., Lee, D., Chung, H.Y. et al. Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancer. J Cancer Res Clin Oncol 139, 1835–1843 (2013). https://doi.org/10.1007/s00432-013-1503-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-013-1503-4

Keywords

Search

Navigation